Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence C Paoletti

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilisMichael J Coyne, Maria Chatzidaki-Livanis, Lawrence C Paoletti, et al.
Vaccine|August 22, 2006
Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adultsCarol J Baker, Marcia A Rench, Lawrence C Paoletti, et al.
Clinical and Vaccine Immunology : CVI|May 9, 2008
Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier proteinHsiao-Hui Yang, Samantha J Mascuch, Lawrence C Madoff, et al.
Human Vaccines|April 21, 2009
A fluorescence-based opsonophagocytosis assay to measure the functional activity of antibody to group B StreptococcusHilde-Kari Guttormsen, Samantha J Mascuch, Julia C West, et al.
Vaccine|April 20, 2005
The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxisAnushua Sinha, Tracy A Lieu, Lawrence C Paoletti, et al.
Journal of Bacteriology|March 13, 2012
Regulation and function of pilus island 1 in group B streptococcusShengmei Jiang, Su Eun Park, Puja Yadav, et al.
Infection and Immunity|July 24, 2004
Adherence to, invasion by, and cytokine production in response to serotype VIII group B StreptococciHiroshige Mikamo, Atul K Johri, Lawrence C Paoletti, et al.
Human Vaccines|April 30, 2008
Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbitsLawrence C Paoletti, Hilde-Kari Guttormsen, Mildred S Christian, et al.
Infection and Immunity|May 2, 2007
Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccinesHsiao-Hui Yang, Lawrence C Madoff, Hilde-Kari Guttormsen, et al.
The Journal of Infectious Diseases|June 26, 2003
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and IIICarol J Baker, Marcia A Rench, Marisol Fernandez, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilisMichael J Coyne, Maria Chatzidaki-Livanis, Lawrence C Paoletti, et al.
Vaccine|August 22, 2006
Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adultsCarol J Baker, Marcia A Rench, Lawrence C Paoletti, et al.
Clinical and Vaccine Immunology : CVI|May 9, 2008
Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier proteinHsiao-Hui Yang, Samantha J Mascuch, Lawrence C Madoff, et al.
Human Vaccines|April 21, 2009
A fluorescence-based opsonophagocytosis assay to measure the functional activity of antibody to group B StreptococcusHilde-Kari Guttormsen, Samantha J Mascuch, Julia C West, et al.
Vaccine|April 20, 2005
The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxisAnushua Sinha, Tracy A Lieu, Lawrence C Paoletti, et al.
Journal of Bacteriology|March 13, 2012
Regulation and function of pilus island 1 in group B streptococcusShengmei Jiang, Su Eun Park, Puja Yadav, et al.
Infection and Immunity|July 24, 2004
Adherence to, invasion by, and cytokine production in response to serotype VIII group B StreptococciHiroshige Mikamo, Atul K Johri, Lawrence C Paoletti, et al.
Human Vaccines|April 30, 2008
Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbitsLawrence C Paoletti, Hilde-Kari Guttormsen, Mildred S Christian, et al.
Infection and Immunity|May 2, 2007
Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccinesHsiao-Hui Yang, Lawrence C Madoff, Hilde-Kari Guttormsen, et al.
The Journal of Infectious Diseases|June 26, 2003
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and IIICarol J Baker, Marcia A Rench, Marisol Fernandez, et al.
Pageof 3